Figure 1 Kaplan Meier survival function by baseline ART regimen
|
Overall |
Intravaginal Misoprostol |
Surgical Evacuation |
Analysis |
Age (years) |
28.0 (25.0,32.8) |
30.0 (25.8,34.0) |
27.0 |
Z=-1.033 |
Ethnicity, n (%)
|
77 (77.0) |
41 (82.0) |
36 (72.0) |
Χ2=5.191 |
Parity, n (%)
|
45 (31.0) |
22 (44.0) |
23 (46.0) |
Χ2=0.040 |
Gestational age (weeks ± IQR) |
10.0 (8.4,11.6) |
10.0 |
10.0 (8.3,11.7) |
Z=-0.031 |
Hb pre-treatment (g/dl ± IQR ) |
12.3 (11.4,13.4) |
12.4 (11.7,13.3) |
12.1 (11.0,13.4) |
Z=-1.249 |
Endometrial thickness (mm ± IQR) |
23.5 (21.0,30.0) |
24.0 (21.0,34.0) |
22.5 (20.0,30.0) |
Z=-1.096 |
Table1 Baseline characteristics
All parameter expressed in median (quartile) unless specified
|
Overall |
Intravaginal Misoprostol |
Surgical Evacuation |
p-value |
Successful evacuation,
|
96 (96.0) |
47 (94.0) |
49 (98.0) |
χ2=1.042 |
Table2 Study outcome
|
Frequency |
Percentage |
1 dose |
13 |
26 |
2 doses |
23 |
46 |
3 doses |
14 |
28 |
Total |
50 |
100 |
Table3 Requirement for misoprostol doses
|
Overall |
Intravaginal Misoprostol |
Surgical Evacuation |
p-value |
Duration of bleeding (days ± IQR) |
7.0 (5.0,7.0) |
6.0 (5.0,7.0) |
7.0 (5.0,7.0) |
Z=-0.688 |
Reduction of Hb day 1 (g/dl ± IQR) |
0.4 (0.0,1.0) |
0.2 (0.0,0.8) |
0.7 (0.2,1.2) |
Z=-2.431 |
Reduction of Hb day 14 |
0.2 (0.0,0.8) |
0.1 (0.0,0.7) |
0.4 (0.0,0.8) |
Z=-1.129 |
Table4 Other clinical outcome
*p < 0.05
All parameter expressed by median (quartile) unless specified
|
Overall |
Intravaginal Misoprostol |
Surgical Evacuation |
p-value |
Nausea, n (%) |
3 (3) |
3 (6) |
0 (0) |
χ2=3.093 |
Vomiting, n (%) |
2 (2) |
2 (4) |
0 (0) |
χ2=2.041 |
Diarrhoea, n (%) |
10 (10) |
10 (20) |
0 (0) |
χ2=11.111 |
Fever, n (%)
|
11 (11) |
11 (22) |
0 (0) |
χ2=12.360 |
Table5 Side effects of both study groups within 24 hours
*p< 0.01